Neuberger Berman Group LLC Iovance Biotherapeutics, Inc. Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 32,878 shares of IOVA stock, worth $64,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,878
Previous 32,878
-0.0%
Holding current value
$64,112
Previous $56,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IOVA
# of Institutions
298Shares Held
234MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$56.5 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$48.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$41.4 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$23 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$19.3 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $308M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...